Bryn Mawr Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$8.9M |
| 2 |
Becton Dickinson
BDX
|
+$7.25M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$4.84M |
| 4 |
Vanguard Total Bond Market
BND
|
+$3.76M |
| 5 |
Broadcom
AVGO
|
+$2.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$17.9M |
| 2 |
Apple
AAPL
|
+$14.1M |
| 3 |
NVIDIA
NVDA
|
+$10.4M |
| 4 |
iShares Russell Top 200 Growth ETF
IWY
|
+$6.48M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.7% |
| 2 | Healthcare | 9.74% |
| 3 | Financials | 8.44% |
| 4 | Consumer Discretionary | 5.54% |
| 5 | Consumer Staples | 5.16% |
Similar funds
Bryn Mawr Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Bryn Mawr Capital Management held 443 positions worth $1.67B, down 10% from $1.86B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bryn Mawr Capital Management withdrew a net $159M in Q1 2025, closing 56 positions and reducing 210 holdings. Its most notable exit was Cintas, an estimated $2.48M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Bryn Mawr Capital Management opened a new position in iShares Russell Mid-Cap ETF worth $1.62M.
- Bryn Mawr Capital Management's largest Q1 2025 buy was iShares Russell Mid-Cap ETF: 19,081 shares worth $1.62M.
- Bryn Mawr Capital Management added most to Royalty Pharma in Q1 2025, an estimated $8.9M increase.
- Bryn Mawr Capital Management's biggest Q1 2025 reduction was Oracle, cutting an estimated $17.9M.
- Bryn Mawr Capital Management fully exited Cintas in Q1 2025, selling an estimated $2.48M.
- Bryn Mawr Capital Management's ten largest holdings make up 32% of its $1.67B portfolio in Q1 2025.
- Bryn Mawr Capital Management opened 31 new positions and closed 56 in Q1 2025.
- Bryn Mawr Capital Management's portfolio value fell 10% quarter-over-quarter to $1.67B.
Based on Bryn Mawr Capital Management's 13F filing for Q1 2025, filed 2 May 2025.